logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

I-Mab

I-Mab and Tracon Begin US Trials of CD73 Antibody

Aug 2, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Adds Former BC Ministry of International Trade Manager as Consultant for Business Development

Aug 1, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid’s Food Processing Facility Certified SQF Level 2 Manufacturing Capacity Increased

Jul 30, 2019

Life Science

Eastwood Bio-medical Canada Inc. (TSXV EBM)

Eastwood Bio-Medical Canada Appoints New Chief Financial Officer

Jul 24, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Sales in Q2 Nearing 100% Increase Year to Date

Jul 24, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Correction: Naturally Splendid Strengthens Marketing Programs in Advance of Edible Markets

Jul 23, 2019

Life Science

Eastwood Bio-medical Canada Inc. (TSXV EBM)

Eastwood Bio-Medical Canada Inc. Announces Partnership with School Specializing in Autistic Spectrum Disorder and Launch of Additional Products

Jul 23, 2019

Life Science

Avalon GloboCare

Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines

Jul 22, 2019

Life Science

GenScript

GenScript Completes Phase I of Nanjing Biologics CDMO R&D/Production Center

Jul 20, 2019

Life Science

Fosun

Shanghai Fosun Partners In-Vitro Lung Cancer Diagnostic with VolitionRx

Jul 20, 2019

Life Science

Celltrion

Celltrion Forms JV with Nan Fung to Develop Three Biosimilars in China

Jul 20, 2019

Life Science

Chipscreen

Chipscreen Poised to be One of the First IPOs on Shanghai’s STAR Exchange

Jul 19, 2019

Life Science

CNRT

CNRT Raises $14 Million; Will Develop BTG’s TheraSphere® in China

Jul 19, 2019

Life Science

Abbisko

Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston’s X4

Jul 19, 2019

Life Science

Boehringer Ingelheim

Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals

Jul 19, 2019

Life Science

EdiGene

EdiGene, a Beijing CRISPR/Cas9 Editing Company, Sells Knockout Cell Line Library to Abcam

Jul 18, 2019

Life Science

Philips

Philips acquires Boston start-up Medumo to help hospitals communicate with patients

Jul 18, 2019

Life Science

Genentech

Genentech Strikes Three Separate Drug Discovery Deals With Small Companies

Jul 17, 2019

Life Science

  • ‹‹ Previous
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada